Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11834039 | 0.83 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL2508336 | 0.83 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL1090946 | 0.81 | — | — | |
| SCHEMBL12478173 | 0.70 | — | — | |
| SCHEMBL635712 | 0.70 | — | — | |
| SCHEMBL42569 | 0.70 | — | — | |
| SCHEMBL15124586 | 0.69 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL20347954 | 0.69 | TSHR (0.40) | ALDH1A1 | |
| SCHEMBL1091205 | 0.69 | — | — | |
| SCHEMBL7309616 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111171298-A | Resin for two-piece can white ink, two-piece can white ink and preparation method thereof | 上海超彩油墨有限公司 | 2020-05-19 | — | — | CN | claimed |
| EP-2454017-A1 | REACTIVE SYSTEMS | Elantas GmbH (DE) | 2012-05-23 | — | — | EP | disclosed |
| WO-2011006798-A1 | REACTIVE SYSTEMS | ELANTAS GMBH (DE) | 2011-01-20 | — | — | WO | disclosed |
| US-20090069396-A1 | Polyene Oxazoles and Processes for Their Preparation | THALLION PHARMACEUTICALS, INC. (CA) | 2009-03-12 | — | — | US | disclosed |
| US-7312339-B2 | Polyene oxazoles and processes for their preparation | THALLION PHARMACEUTICALS INC. (CA) | 2007-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069396-A1 | Polyene Oxazoles and Processes for Their Preparation | OXA1L, SQLE, OXER1 | ALDH1A1 4307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.